|Stereotactic body radiation therapy for inoperable early stage lung cancer|
R Timmerman, R Paulus, J Galvin, J Michalski, W Straube, J Bradley, ...
Jama 303 (11), 1070-1076, 2010
|Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or …|
JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ...
The lancet oncology 16 (2), 187-199, 2015
|Radiation dose–volume effects in the lung|
LB Marks, SM Bentzen, JO Deasy, JD Bradley, IS Vogelius, I El Naqa, ...
International Journal of Radiation Oncology* Biology* Physics 76 (3), S70-S76, 2010
|Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancer|
J Bradley, WL Thorstad, S Mutic, TR Miller, F Dehdashti, BA Siegel, ...
International Journal of Radiation Oncology* Biology* Physics 59 (1), 78-86, 2004
|A method for the reconstruction of four‐dimensional synchronized CT scans acquired during free breathing|
DA Low, M Nystrom, E Kalinin, P Parikh, JF Dempsey, JD Bradley, S Mutic, ...
Medical physics 30 (6), 1254-1263, 2003
|Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis|
DA Palma, S Senan, K Tsujino, RB Barriger, R Rengan, M Moreno, ...
International Journal of Radiation Oncology* Biology* Physics 85 (2), 444-450, 2013
|Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung …|
J Bradley, MV Graham, K Winter, JA Purdy, R Komaki, WH Roa, JK Ryu, ...
International Journal of Radiation Oncology* Biology* Physics 61 (2), 318-328, 2005
|Impact of intensity-modulated radiation therapy technique for locally advanced non–small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized …|
SG Chun, C Hu, H Choy, RU Komaki, RD Timmerman, SE Schild, ...
Journal of Clinical Oncology 35 (1), 56, 2017
|Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response|
JA Ajani, K Winter, GS Okawara, JH Donohue, PWT Pisters, CH Crane, ...
Journal of clinical oncology 24 (24), 3953-3958, 2006
|In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM|
F Dehdashti, MA Mintun, JS Lewis, J Bradley, R Govindan, R Laforest, ...
European journal of nuclear medicine and molecular imaging 30 (6), 844-850, 2003
|18F-FDG PET definition of gross tumor volume for radiotherapy of non–small cell lung cancer: is a single standardized uptake value threshold approach appropriate?|
KJ Biehl, FM Kong, F Dehdashti, JY Jin, S Mutic, I El Naqa, BA Siegel, ...
Journal of Nuclear Medicine 47 (11), 1808-1812, 2006
|Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus|
T Ritter, DJ Quint, S Senan, LE Gaspar, RU Komaki, CW Hurkmans, ...
International Journal of Radiation Oncology* Biology* Physics 81 (5), 1442-1457, 2011
|Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma|
JD Bradley, N Ieumwananonthachai, JA Purdy, TH Wasserman, ...
International Journal of Radiation Oncology* Biology* Physics 52 (1), 49-57, 2002
|Positron emission tomography in limited-stage small-cell lung cancer: a prospective study|
JD Bradley, F Dehdashti, MA Mintun, R Govindan, K Trinkaus, BA Siegel
Journal of Clinical Oncology 22 (16), 3248-3254, 2004
|Stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer|
TD Crabtree, CE Denlinger, BF Meyers, I El Naqa, J Zoole, AS Krupnick, ...
The Journal of thoracic and cardiovascular surgery 140 (2), 377-386, 2010
|Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen|
L Henke, R Kashani, C Robinson, A Curcuru, T DeWees, J Bradley, ...
Radiotherapy and Oncology 126 (3), 519-526, 2018
|Long-term results of NRG oncology RTOG 0617: standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non–small-cell lung cancer|
JD Bradley, C Hu, RR Komaki, GA Masters, GR Blumenschein, SE Schild, ...
Journal of Clinical Oncology 38 (7), 706, 2020
|Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy|
AK Singh, MA Lockett, JD Bradley
International Journal of Radiation Oncology* Biology* Physics 55 (2), 337-341, 2003
|Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non–small-cell lung cancer: NRG oncology/RTOG 0813 trial|
A Bezjak, R Paulus, LE Gaspar, RD Timmerman, WL Straube, WF Ryan, ...
Journal of Clinical Oncology 37 (15), 1316, 2019
|Novel breathing motion model for radiotherapy|
DA Low, PJ Parikh, W Lu, JF Dempsey, SH Wahab, JP Hubenschmidt, ...
International Journal of Radiation Oncology* Biology* Physics 63 (3), 921-929, 2005